689 results on '"Cerbai, Elisabetta"'
Search Results
2. Oral anticoagulation in patients with left ventricular thrombus – a systematic review and meta-analysis
3. Slower Calcium Handling Balances Faster Crossbridge Cycling in Human MYBPC3 HCM
4. Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
5. Optogenetic confirmation of transverse‐tubular membrane excitability in intact cardiac myocytes
6. Neural Effects on Cardiac Electrophysiology : Interplay Between Beta-Adrenergic Receptors and Ion Channels
7. Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies
8. Interleukin-6 Modulates the Expression and Function of HCN Channels: A Link between Inflammation and Atrial Arrhythmogenesis
9. Interleukin-6 Modulates the Expression and Function of Hcn Channels: A Link Between Inflammation and Atrial Electrical Remodelling
10. Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: A Translational Study
11. Novel pharmacological approaches for paediatric hypertrophic cardiomyopathy
12. Cardiac safety assessment of a novel recombinant bispecific antibody targeting the ether-à-go-go related gene 1 (hERG1)-β1 integrin macromolecular complex
13. Myocardial 123I-metaiodobenzylguanidine imaging in hypertension and left ventricular hypertrophy
14. Sex-related differences in chronic heart failure
15. Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center
16. Toward an in vitro human pacemaker
17. Content of mitochondrial calcium uniporter (MCU) in cardiomyocytes is regulated by microRNA-1 in physiologic and pathologic hypertrophy
18. Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome
19. New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022
20. New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023
21. Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
22. Neural Effects on Cardiac Electrophysiology
23. Hyperpolarization-activated cyclic-nucleotide-gated channels: pathophysiological, developmental, and pharmacological insights into their function in cellular excitability
24. Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM
25. New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022
26. Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy
27. The importance of integrated left atrial evaluation: From hypertension to heart failure with preserved ejection fraction
28. Development of Light-Responsive Liquid Crystalline Elastomers to Assist Cardiac Contraction
29. Genetic characterization of juvenile sudden cardiac arrest and death in Tuscany: The ToRSADE registry
30. Optogenetic manipulation of cardiac electrical dynamics using sub-threshold illumination: Dissecting the role of cardiac alternans in terminating rapid rhythms
31. Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency
32. Interleukin 6 rapidly modifies hyperpolarization-activated Cyclic nucleotide–gated (HCN) channel expression in vitro and its level is linearly related to HCN isoforms in human atria
33. Extracellular stiffness as a determinant of cardiac dysfunction in Duchenne's muscular dystrophy: A study on human iPSC-derived cardiomyocytes
34. Dual effect of hydrogen-sulfide on the hyperpolarization-activated inward current (If) in human atrial cardiomyocytes
35. Cellular determinants of arrhythmic risk in hypertrophic cardiomyopathy
36. Effects of mavacamten in human myocardium from hypertrophic obstructive cardiomyopathy (HOCM) patients: A comparison with disopyramide
37. Mesoscopic optical imaging of whole mouse heart
38. Muscle RING finger-1 is required to prevent age-related cardiac hypertrophy and interstitial remodelling
39. Pharmacological basis of the antifibrotic effects of pirfenidone: Mechanistic insights from cardiac in-vitro and in-vivo models
40. Defects in T-tubular electrical activity underlie local alterations of calcium release in heart failure
41. Arterial hypertension and atrial fibrillation: standard and advanced echocardiography from diagnosis to prognostication
42. Acute appendicitis in a patient immunised with COVID‐19 vaccine: A case report with morphological analysis
43. Photoresponsive Polymer‐Based Biomimetic Contractile Units as Building Block for Artificial Muscles
44. Sex‐Related Differences in Genetic Cardiomyopathies
45. Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy: cellular mechanisms and implications for diastolic function
46. Optogenetic manipulation of cardiac electrical dynamics using sub-threshold illumination: Dissecting the role of cardiac alternans in terminating rapid rhythms
47. Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease:A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
48. The effects of gender on electrical therapies for the heart: physiology, epidemiology, and access to therapies
49. Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic Cardiomyopathy
50. Acute appendicitis in a patient immunised with COVID‐19 vaccine: A case report with morphological analysis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.